Back
to BiopharmaceuticalGlossaries.com
You are here Biopharmaceutical/
Genomic
Glossary
Homepage > Drug discovery & development term index
Drug discovery, development & diagnostics
term index
Not a comprehensive list of terms, but a
quick and dirty finding aid while I'm working on getting these glossaries into a
(long overdue) searchable database. Chemistry
term index Healthcare Term Index Informatics
term index Technologies term
index Molecular Biology
term index
Ethics
CHI’s Drug Discovery and Development Map
Drug discovery &
development commentary
Biologics
: adaptive T cell therapy, antibody... , antibody drug conjugates, antibody
engineering, antigen, antisense therapy, biological pharmacokinetics, biological
product, biologics, biopharmaceutical, bispecific…, biotechnology,
biotransformation, CAR T, cell based therapies, cellular therapy, chimeric
antigen receptors, developability biologics, DNA vaccines, domain antibodies,
fusion protein therapeutics, gene therapy, humanized antibodies,
immunotechnology, immunotherapy, immunotoxins, molecular therapeutics,
monoclonal, multispecific antibodies, next generation antibodies,
oligonucleotide therapeutics, PEGs, PepTalk, peptide therapeutics, polyclonal,
protein therapeutics, recombinant…, reverse vaccinology, therapeutic antibodies,
, vaccine , veterinary biologics Biologics
overview See also Pharmacogenomics
Bioprocessing
analytical development, baculovirus, biomanufacturing, bioprocess,
bioproduction, bioreactors, cell culture, cell line, , cell strain, cell
therapy CMC, cGMP current Good Manufacturing Practice, characterization
methods, CHO Chinese Hamster Ovary cells, comparability, , continuous
processing, cultured cells, disposables, downstream processing, dynamic
light scattering, expression vector , fluidic systems, freeze drying,
gene therapy CMC, Good Manufacturing Practice GMP, host cell proteins,
host vector system, lyophilization, manufacturing 4.0, method development,
microbial production, , microreactors, molecular farming, oligonucleotide
CMC, pharming, Process Analytical Technology PAT , process
characterization, process chemistry, protein expression, protein
production, protein purification, recombinant protein expression, single
use technologies, tissue culture, upstream processing, vector….
Drug
delivery & formulation
active transport, adjuvant…, bioavailability, bioequivalence, biological
availability, biologics formulation , biopharmaceutics, blood brain
barrier, carrier mediated drug transport, cosolvent, crystalline, dosage
form, drug delivery…, drug eluting stent, drug targeting, formulation, insulin
infusion systems, liposome, micelle, microfiltration, microsphere, molecular
pharmaceutics, nanodelivery, nanoencapsulation, nanoparticles, nucleotide
delivery, oligonucleotide delivery, ophthalmological delivery,
parenteral, pharmaceutics, pharmacodelivery, polymorph, polymorphic,
polymorphism, preformulation, prodrug, protein delivery, targeted drug
delivery, therapeutic equivalence
Drug
discovery & development Adaptive
Design, benchmarking, best practices, big pharma, biomedical companies, ,
biotechnology ..., blockbuster, brand name sector, business intelligence,
business models R&D, business rules, Centers for Medicare and Medicaid Services
CMS, , competitive ..., compound annual growth rate CAGR, corporate DNA, CXO
Executive Summit, disintermediation, disruptive technologies, drug development
costs, ebXML, elevator pitch, emerging growth companies, emerging technologies,
EphMrA, fail fast, FIPCO Fully Integrated Pharmaceutical Company, , franchises,
GICS Global Industry Classification Standard, health spending, high tech
industry, hype, hypercompetitive, incubators, KOL Key Opinion Leaders, lead
users, life cycle management, market ..., marketing, megabrands, METI Ministry
of Economy, Trade & Industry, milestones, multibusters, NAICs North American
Product Classification System, niche busters, open source intelligence,, payers
payors, pharmaceutical industry, pharmaceutical marketing, pharmaceutical
spending, portfolio management, price trends – prescription drugs, process
optimization, productivity, project portfolio management, proof of concept,
proof of principle, reimbursement, reverse pharmacology, risk, sexy technologies, Small & Medium
sized Enterprises SMEs, specialty pharmaceuticals, spin-offs, stage gate
criteria, start-ups…, strategic resource management, technology ..., time to
market, unicorn companies, white space, XBRL See also Biologics,
Cancer, Pharmacogenomics
Drug
discovery & development Overview
Drug
discovery informatics
Biosemantics Group, CADD Computer Assisted Drug
Design, computational drug design..., de novo design, drug design, eScience
Lab, immunoinformatics, in silico ... , LIMS Laboratory Information Management
Systems, molecular informatics, molecular mimicry, NeuroCommons,
pharmacometrics, rational drug design, receptor mapping, simulations, soft drug
design, structure based drug design, synthetic biology, virtual screening See
also Cheminformatics,
Drug
safety & pharmacovigilance Adaptive
Design, benchmarking, best practices, big pharma, biomedical companies, ,
biotechnology ..., blockbuster, brand name sector, business intelligence,
business models R&D, business rules, Centers for Medicare and Medicaid Services
CMS, , competitive ..., compound annual growth rate CAGR, corporate DNA, CXO
Executive Summit, disintermediation, disruptive technologies, drug development
costs, ebXML, elevator pitch, emerging growth companies, emerging technologies,
EphMrA, fail fast, FIPCO Fully Integrated Pharmaceutical Company, , franchises,
GICS Global Industry Classification Standard, health spending, high tech
industry, hype, hypercompetitive, incubators, KOL Key Opinion Leaders, lead
users, life cycle management, market ..., marketing, megabrands, METI Ministry
of Economy, Trade & Industry, milestones, multibusters, NAICs North American
Product Classification System, niche busters, open source intelligence,, payers
payors, pharmaceutical industry, pharmaceutical marketing, pharmaceutical
spending, portfolio management, price trends – prescription drugs, process
optimization, productivity, project portfolio management, proof of concept,
proof of principle, reimbursement, risk, sexy technologies, Small & Medium
sized Enterprises SMEs, specialty pharmaceuticals, spin-offs, stage gate
criteria, start-ups…, strategic resource management, technology ..., time to
market, unicorn companies, white space, XBRL
Drug Targets
agonist immunotherapy targets,
allosteric modulators, autophagy, biological target, cancer cell metabolism,
channel blocker, Chimeric Antigen Receptors CAR, constrained peptides, cytokine
based therapeutics, cystoplasmic and nuclear receptors, Discovery on
Target, disease targets, drug targets…drug transporters, DrugBank, druggable
targets, efficacy targets, epigenetic targets, gene target, gene targeting,
GPCRs G protein coupled receptors, histone demethylases, histone
deacetylase Inhibitors HDAC, inflammation & autoimmune inhibitors, ion
channels, kinases, macrocyclics, membrane proteins, membrane proteomics,
microbiome, molecular drug targets, Molecular Pharmacopeia, molecular targeted
therapy, molecular targets, multi-targeted therapies, Nf-Kappa B, nuclear
hormone receptors, nuclear receptors, orphan G-protein coupled receptors, orphan
nuclear receptors, phosphoinositide 3Kinase PI3K, protease inhibitors, protein
families, protein kinases, protein protein interactions, retargeting, target ,
target characterization, target engagement, target families, target hopping,
target identification, target labelling, target prioritization, target proteins,
target qualification, target selection, , target validation, targeted gene
repair, targeted therapy, Therapeutic targets Database, tractable targets,
ubiquitin [as a drug target], virtual target screening
Pharmaceutical
biology active center, agonist, analog, antagonist,
antisense…aptamer, , binding…,deorphanize, drug leads, drug receptors, ,
efficacy, enzymes … epitope, homologue, hormone, ,inhibitors, intrinsic
activity, ligand, paratope, permeability, pharmacophores, prodrug, promiscuous
drugs, promiscuous inhibitors, receptors, recognition
site, selectivity, solubility, specificity, substrate
Regulatory
21 CFR Part 11, accelerated approval,
Advanced Therapy Medicinal Products ATMPS, analyte specific reagents,
biogenerics, biosimilars, borderline products, brand name drugs, CBER, CDER,
children in research, CLIA, Clinical Research Policy Analysis and Coordination
CRPAC, combination products, Committee on Human Medicines, common technical
document, compassionate use, cosmeceuticals, drug, effective, EMEA, expanded
access, exploratory IND, fast track, FDA…, FDAMA, follow ons, GCP Good Clinical
practice, generic drugs, GLP Good Laboratory Practice, guidance documents FDA,
GxP, harmonization, HIPAA, home brew, ICH International Conference on
Harmonisation, IND, informed consent, IRB, me too, MedWatch, Medicines &
Healthcare Regulatory Authority MHRA, NCE, NDA, NME, non-prescription drugs, off
label, openFDA, orphan …., PDUFA, predicate rules, prescription drugs, priority
review, proprietary drug, , regulatory agencies, safe harbor, specified
biotechnology products, third party review, well characterized biotechnology
products, women and minorities
Clinical
trials adaptive clinical
trials, adaptive licensing, Artificial Intelligence in clinical trials,
attrition, basket trials, big data , clinical..., clinical trials, computable
phenotypes, CONSORT, CRO Clinical Research Organization, developmental site
agreements, efficacy trials, enrichment strategies, enrollment planning,
expansion cohort, explanatory trials, forecasting budgeting & contracting,
intervention, large simple trials, late stage research & observational trials,
lure of initial value, measurements, NIH Collaboratory, outsourced outsourcing,
patient, patient-centric, patient engagement, patient recruitment, Patient
Reported Outcomes, Phase I, II, III, IV, phase zero, pivotal clinical trials,
placebo non and placebo responders, pragmatic clinical trials, protection of
human subjects, protocol…, Randomized Clinical Trials RCTs, real world data,
resource management, risk based monitoring, sensors wearables & digital
biomarkers, site…, stratification, subject, umbrella trials
Molecular Diagnostics
including Genetic
& genomic testing
$1,000 genome, analyte specific reagents, analytical selectivity, analytical
sensitivity, analytical specificity, capsule endoscopy, carrier testing, clinical
chemistry, clinical Next Generation Sequencing diagnostics, clinical
sensitivity, clinical specificity, combination drug diagnostics, combination
products, companion diagnostics, Computer Aided Detection CAD, Computer Aided
Diagnosis CADx, “designer” babies, diagnosis, diagnostics, diagnostics
automation, digital health,
digital pathology, family history, general purpose reagent, GeneReviews,
genetic counseling, genetic discrimination, genetic enhancement, genetic
predisposition, genetic privacy, genetic screening, genetic
susceptibility, genetic test, germ cells, germline mutation, "good
genes bad genes”, in vitro diagnostic multivariate index assays IVDMIAs, in
vitro diagnostics IVDs, Laboratory Developed Tests LDTs, medical genetics,
medical genomics, molecular biopsy, molecular diagnostics, molecular pathology,
multiplex assays, newborn screening, patient stratification, point of care
diagnostics, preconception testing, predictive testing, predisposition,
preimplantation diagnosis, prenatal diagnosis, presymptomatic test, research
diagnostics, risk communication, SACGT Secretary’s Advisory Committee on Genetic
Testing, sample prep, screening, sensitivity, sex selection, single cell
analysis, somatic cells, susceptibility, theranostics
Molecular Medicine
All of US Research program, behavior …, chronome, chronotherapy, clinical
proteomics, cogneceutials, cryomedicine, cryosurgery, cryotherapy,
determinism [genetic] , disease... , drug utilization review, environmental
factors, epidemiology, experimental medicine, functional
foods, genetics, genotypic prevention, global health, glycogerontology, health
disparities, human gene transfer, human microbiome, Medbiquitous
Consortium, medical errors, molecular ..., morbidity compressing, mortality
reducing, nanomedicine, NIGMS, normal, nutriceuticals, nutrigenomics,
nutritional genomics, phenotypic prevention, public health, quantified self,
rare diseases, regenerative medicine, translational medicine, translational
science, uncertainty, women’s health, , world health
Patient resources
Pharmacogenomics
ADME ..., ADME/Tox, chronopharmaokinetics, chronopharmacology, clinical
pharmacology, computational pharmacology, CRISPR for precision medicine,
cytochrome p450 enzymes, disease resistant individuals DMPK, drug
metabolism, Drug Metabolizing Enzymes DME, drug response, expression
pharmacogenomics, FDA guidelines pharmacogenomics, flip flop pharmacokinetics,
genomic data, genotype-to phenotype, immunophenotyping, in silico pharmacology,
individualized medicine, integrative and organ systems pharmacology, kinetic
outliers, mechanism of action MOA, median effective
dose, metabonomics/metabolomics, microbiome based precision medicine, mode of
action MoA, molecular mechanisms of action, molecular pharmacology, molecular
phenotyping, network pharmacology, personalized medicine,
pharmacodynamics, pharmacoepigenomics, pharmacogenetics, pharmacogenomics, pharmacokinetics, pharmacometabonomics,
pharmacophylogenomics, pharmacoproteomics, phenotype…., Polypharmacology,
precision diagnostics, precision medicine, predictive ..., quantitative
pharmacology, quantitative systems pharmacology, systems
pharmacology, therapeutic equivalency, therapeutic index, translational
pharmacodynamics, Voluntary Genomic Data Submissions VGDS
Therapeutic
areas: Cardiovascular CNS & Neurology Immunology
Infectious Diseases Inflammation
Alzheimer's, antibacterial, antibiotic, antivirals, autistic disorder,
autoimmune & inflammation, biodefense, blood substitutes, BSE, CJD, cardiac…,
cardiovascular, cosmetic psychopharmacology, diabetes, emerging infectious,
hepatitis, HIV, immunogenetics, immunogenomics, immunological, infectious,
inflammation, lipoproteomics microbial proteomics, NASH & Fibrosis,
neuroceuticals, NeuroCommons, neurodegenerative, neuropharmaceuticals,
neuroproteomics, Neurotech investing, obesity, ophthalmology, prion,
psychogenomics, psychoneuroimmunology, systems immunotechnology
Drug discovery & Healthcare Resources
Drug
safety Conferences http://www.healthtech.com/Conferences/Search.aspx?k=&r=&s=DSF
Clinical
trials Conferences
http://www.healthtech.com/conferences/upcoming.aspx?s=CTL
Diagnostics
Conferences http://www.healthtech.com/Conferences/Search.aspx?k=&r=&s=BMK
Healthcare
Conferences http://www.healthtech.com/Conferences/Search.aspx?k=&r=&s=HLTS
Therapeutic
indications Conferences: http://www.healthtech.com/Conferences/Search.aspx?k=&r=&s=RXXS
Contact | Privacy
Statement | Alphabetical
Glossary List | Tips
& glossary FAQs | Site
Map
Evolving Terminology for Emerging Technologies
Comments? Questions?
Revisions? Mary Chitty mchitty@healthtech.com
Last revised
July 12, 2019
<%end if%>
Business
of biopharmaceuticals Adaptive Design, benchmarking, best
practices, big pharma, biomedical companies, , biotechnology ...,
blockbuster, brand name sector, business intelligence, business models
R&D, business rules, Centers for Medicare and Medicaid Services CMS, ,
competitive ..., compound annual growth rate CAGR, corporate DNA, CXO
Executive Summit, disintermediation, disruptive technologies, drug
development costs, ebXML, elevator pitch, emerging growth companies,
emerging technologies, EphMrA, fail fast, FIPCO Fully Integrated
Pharmaceutical Company, , franchises, GICS Global Industry Classification
Standard, health spending, high tech industry, hype, hypercompetitive,
incubators, KOL Key Opinion Leaders, lead users, life cycle management,
life sciences, market ..., marketing, megabrands, METI Ministry of Economy, Trade &
Industry, milestones, multibusters, NAICs North American Product
Classification System, niche busters, open source intelligence,, payers
payors, pharmaceutical industry, pharmaceutical marketing, pharmaceutical
spending, portfolio management, price trends – prescription drugs, process
optimization, productivity, project portfolio management, proof of
concept, proof of principle, reimbursement, risk, sexy technologies,
Small & Medium sized Enterprises SMEs, specialty pharmaceuticals,
spin-offs, stage gate criteria, start-ups…, strategic resource
management, technology ..., time to market, unicorn companies, white
space, XBRL
Biopharmaceutical
Alliances alliances, collaboration, competitive advantage, consortium,
CORDIS Community Research and Development Information Services,
Cooperative research and Development Agreements CRADA, discovery rights,
expectations management, extension of agreement, joint venture, keiretsu,
NCRPA, partnership, SBIR Small Business Innovation Research, STRR Small
Business Technology Transfer,, strategic alliances, technology consortia,
Technology Research Association TRA, technology service agreement
Biopharmaceutical
Finance A rounds, accredited investors, angel investor, annual reports,
anti-dilution, behavioral finance, BioIT Investing and partnering,
biopharmaceutical R&D financing, burn rate, clawback, convertible,
dilution, down rounds, drug costs, early stage…, equity investments, exit
strategies, financing, full ratchet, funding of genomic research, health
economics, Immuno-Oncology Investing, Initial Public Offering IPO,
liquidity event, mergers & acquisitions M&D, mezzanine financing, Net
Present Value NPV< Neurotech Investing, opportunity costs, partial
acquisition, pharmaceutical fees, pharmacoeconomics, Private Investments
in Public Equity PIPEs, prescription fees, pricing of drugs, private
equity, profit hunts, quids, ratchets, real option valuation, risk…, ROI
return on investment, risk, seed …, serial entrepreneurs, strategic
investors, technology growth, tender offer, term sheet, tranche,
valuation, venture capital, venture debt, venture leasing, venture
philanthropy, warrant, washout round, white space
Biopharmaceutical
Law & Intellectual property anti-trust, Bayh- Dole, Bilski vs.
Kappos, biological patent, blocking patents, Cohen- Boyer,
cross-licensing, Diamond vs. Chakrabarty, disease gene patents, DNA
patents, electronic lab notebooks, European Patent Office EPO, EST
patents, exclusivity, gene patents, genomic patents, human life
patenting, Intellectual Property IP, international patents, Japanese
Patent Office JPO, license, licensing, Material Transfer Agreement MTA,
Myriad gene patents, non-obvious, novelty, patent ..., Patent & Trademark
Office PTO, patent cliff, patent pools, patent stacking, patent thicket,
patent trolls, prior art, reach through provisions, research exemptions,
royalty stacking, safe harbor, SNP patents, software partnerships, stealth
patents, submarine patents, technology transfer, trade secret, university
industry partnerships, and IP, utility guidelines, utility patents W3C
patent policy, World Intellectual Property Office WIPO
Healthcare term index
Cancer & Immuno-Oncology IO adoptive cell based cancer
immunotherapy, adoptive T cell therapy, animal models cancer, antibodies cancer
therapy, antimetabolites, Antineoplastic Agents, Immunological, autoantibodies, biological tumor markers, bispecific
antibodies for oncology, cancer biomarkers, cancer genomics, cancer Immunome
Atlas, cancer immunotherapies, cancer informatics, cancer proteomics, cancer
resources for patients, cancer vaccines, CAR T cell therapy, , cellular oncogene
(proto-oncogene), chemoprediction, circulating cell free DNA, circulating tumor
cells, Comparative Oncology Program, driver mutations, early detection of
cancer, familial cancer, FDA Office of Hematology and Oncology Products,
galectinomics, Gleevec, hematological cancer therapies, Herceptin, hereditary
cancer, Immuno-Oncology IO…,immunomodulatory, immunotherapy, imprecision
medicine, Interagency Council on BioMedical Imaging in Oncology, liquid biopsy,
mathematical oncology, molecular profiling, molecular targets, neoadjuvant
therapy, myeloid cells, neoantigen …, NK Natural Killer Cells…., oncogene…,
oncolytic virotherapy, oncosomes, p53, passive immunotherapies, patient
navigation, precancerous, preclinical oncology, predictive oncology, preventive
oncology, proto-oncogene…, solid tumors, sporadic cancer, targeted therapy,
therapy ladders, tumor antigen, tumor markers, tumor microenvironment, tumor
models, tumor myeloid, tumor suppressor genes, tumoroid, tumour…
Clinical
& Medical informatics : adaptive clinical trials, AI and healthcare,
Bayesian clinical trials, Bayesian networks, biomathematics, biomedical
informatics, case definitions, CDISC, clinical data repositories, clinical
forecasting, clinical informatics, clinical research, clinomics, cohort
studies, communications standards, comparative effectiveness research, complex
diseases, computational phenotypes, computational physiology, computational
therapeutics, consumer health informatics, digital health digital therapeutics,
drug utilization, e-health, electronic data capture, electronic medical
records, electronic prescribing, electronic records FDA, evidence based
medicine, genomic epidemiology, health informatics, health IT tools, health
record, healthcare informatics, HL7 Health Level 7, human factors,
immunoinformatics, in silico clinical trial, in silico pharmacology, laboratory
informatics, LOINC Logical Observation Identifiers Names and Codes, meaningful
use, medical bioinformatics, medical informatics, MEDRA, meta-analysis,
meta-regression mHealth mobile health, National Center for Integrative
Biomedical Informatics, National Electronic clinical Trials and Research NECTAR,
neuroimaging, neuroinformatics, Office of the National Coordinator for Health
Information Technology (ONC), outcomes research, pathology informatics, patient
engagement, patient reported outcomes, Personal Health Record PHR,
pharmacoepidemiology, population health, predictive genomics, predictive
pharmacogenomics, prognosis, public health informatics, Real World Data RWD,
Real World Evidence RWE, systems medicine, syndromics, telehealth,
telemedicine, SNOMED, UMLS, uncertainty, universal trial number
Biomarkers biological
markers, biomarkers, biosignatures, clinical endpoints, digital
biomarkers, disease markers, efficacy biomarkers, genetic biomarkers, “ideal”
biomarkers, markers, protein biomarkers, safety biomarkers, surrogate ... ,
type 0, type I, type II biomarkers, valid biomarkers
Biologics
Conferences http://www.healthtech.com/Conferences/Search.aspx?k=&r=&s=PTTS
Biologics Short courses http://www.healthtech.com/Conferences_Upcoming_ShortCourses.aspx?s=PTTS
Molecular Medicine Tri Conference http://www.triconference.com/
PepTalk The Protein Science Week http://www.chi-peptalk.com/
Protein Engineering Summit PEGS http://www.pegsummit.com/
Bioprocessing
Conferences http://www.healthtech.com/Conferences/Search.aspx?k=&r=&s=BPS
Bioprocessing Summit http://www.bioprocessingsummit.com/
PepTalk The Protein Science Week http://www.chi-peptalk.com/
Protein Engineering Summit PEGS http://www.pegsummit.com/
Bioprocessing
CDs, DVDs http://www.healthtech.com/medialibrary/?s=BPS
Bioprocessing
Short courses http://www.healthtech.com/Conferences_Upcoming_ShortCourses.aspx?s=BPS
Drug
discovery & development Conferences
http://www.healthtech.com/conferences/upcoming.aspx?s=DDV
Discovery on Target http://www.healthtech.com/DOT/
Molecular Medicine Tri Conference http://www.triconference.com/
World Pharmaceutical Congress WPC http://www.worldpharmacongress.com/
Drug
discovery & development CDs, DVDs http://www.healthtech.com/medialibrary/?s=DDV
Drug discovery & development Short courses http://www.healthtech.com/Conferences_Upcoming_ShortCourses.aspx?s=DDV
World Pharmaceutical Congress WPC http://www.worldpharmacongress.com/
Drug safety CDs, DVDs http://www.healthtech.com/Conferences/CompactDiscSearch.aspx?k=&r=&s=DSF
Drug safety Short courses http://www.healthtech.com/Conferences_Upcoming_ShortCourses.aspx?s=DSF
Drug safety Barnett Web Seminars http://www.barnettinternational.com/EducationalServices/Search.aspx?k=&t=&j=Drug%20Safety&s=&e=&r=
Drug targets Conferences http://www.healthtech.com/Conferences/Upcoming.aspx?s=TRGS
Discovery on Target
http://www.discoveryontarget.com/
Drug targets CDs, DVDs http://www.healthtech.com/Conferences/CompactDiscs.aspx?s=TRGS
Drug targets Short courses http://www.healthtech.com/Conferences_Upcoming_ShortCourses.aspx?s=TRGS
BioIT World Expo http://www.bio-itworldexpo.com/
SCOPE Summit for Clinical Operations Executives http://www.scopesummit.com/
Clinical Trials Short courses http://www.healthtech.com/Conferences_Upcoming_ShortCourses.aspx?s=CTL
Clinical Trials Barnett books http://www.barnettinternational.com/EducationalServices/Publications.aspx
Clinical Trials Barnett Core Curriculum http://www.barnettinternational.com/EducationalServices/Seminars.aspx
Clinical Trials Barnett Web Seminars http://www.barnettinternational.com/EducationalServices/Webinars.aspx
Molecular Medicine Tri Conference http://www.triconference.com/
Diagnostics Short courses http://www.healthtech.com/Conferences_Upcoming_ShortCourses.aspx?s=BMK
Insight Pharma Reports Biomarkers and Diagnostics http://www.insightpharmareports.com/Biomarker-Diagnostics-Reports/
BioIT
World Expo http://www.bio-itworldexpo.com/
Molecular Medicine TriConference http://www.triconference.com/
Healthcare CDs,
DVDs http://www.healthtech.com/medialibrary/?s=HLTS
Therapeutic indications CDs, DVDs http://www.healthtech.com/Conferences/CompactDiscSearch.aspx?k=&r=&s=RXXS
Therapeutic indications Short courses http://www.healthtech.com/Conferences_Upcoming_ShortCourses.aspx?s=RXXS
Molecular Med Monthly
subscriptions
http://www.healthtech.com/newsletter_reg.asp
How
to look for other unfamiliar terms
Back to GenomicGlossaries.com